JAK Inhibitor Ruxolitinib CRUX Safety and Feasibility Trial Brain 2 Mins Read2 Dr. David Peereboom from Cleveland Clinic conducted a phase one clinical trial called CRUX to investigate the efficacy and safety…
Momelotinib a JAK inhibitor vs Danazol in Myelofibrosis Myeloproliferative Disease 14 Mins Read3 Momelotinib Shows Promising JAK and ALK2 Inhabitation in Patients With Anemic Myelofibrosis: MOMENTUM Study It’s my pleasure today to discuss…
